Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Once Burned, Twice Shy? Pharma Urged To Engage On Entitlement Reform

Executive Summary

Despite the current challenges to the ACA, the biopharmaceutical industry should engage proactively with lawmakers as Medicare and Medicaid face major reforms in the coming years, health policy experts urge at PhRMA’s annual meeting.

You may also be interested in...



Improved Adherence To Diabetes Drugs Can Lower Hospitalizations 13%, Study Finds

Researchers at Harvard and Express Scripts estimate that improved adherence to diabetes drugs could save nearly $5 billion annually across the U.S. health care system.

Reimbursement News, In Brief

Only 11% of physicians plan to apply for EHR federal incentives and appeared about to meet about two-thirds of “meaningful use” requirements, Health Affairs analysis finds; Part D expenditures are increasing by almost 9% annually and rebates are about 11%.

Voices From The Bench: Supreme Court Justices Probe The Affordable Care Act

“The Pink Sheet” highlights intriguing, and perhaps telling, comments by U.S. Supreme Court justices from three days of oral arguments pertaining to the constitutionality of the Affordable Care Act, including the constitutionality of the “individual mandate” for insurance coverage, its severability from other ACA provisions, and whether new Medicaid requirements are an unconstitutional coercion of the states.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS054391

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel